Biomarkers

OARSI White Paper- OA as a Serious Disease
Various

The Pre-Competitive Consortium for Osteoarthritis, an initiative of the Osteoarthritis Research Society International, submitted a White Paper entitled Osteoarthritis as a Serious Disease to the U.S. Food and Drug Administration on December 1, 2016.

fNIH OA Biomarkers Consortium Update
Virginia Kraus, David Hunter, Michael Nevitt

The slides from the OARSI 2015 Pre- Congress Workshop  on the fNIH OA Biomarkers Consortium Project in Seattle have now been posted to the OARSI website